RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Experimental Mammary Neoplasms
Accession: DOID:9005233
browse the term
Definition: Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS.
Synonyms: exact_synonym: Experimental Mammary Neoplasm
primary_id: MESH:D008325
G
Abcb1a
ATP binding cassette subfamily B member 1A
ISO
RGD
PMID:19654309
RGD:2315553
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:14633655 PMID:19654309
RGD:2315553
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Abcg2
ATP binding cassette subfamily G member 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:22767648
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Acsl1
acyl-CoA synthetase long-chain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
G
Actb
actin, beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
G
Actg1
actin, gamma 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232 Ensembl chr 3:105,619,737...105,624,232
G
Actn4
actinin alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:84,182,783...84,251,867
Ensembl chr 1:84,182,788...84,251,847
G
Adcy5
adenylate cyclase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr11:65,471,612...65,618,877
Ensembl chr11:65,471,612...65,618,974
G
Adipoq
adiponectin, C1Q and collagen domain containing
disease_progression treatment
ISO IEP
RGD
PMID:19447866 PMID:22246620
RGD:8694414 , RGD:8694468
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Afp
alpha-fetoprotein
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16322315
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
G
Agt
angiotensinogen
treatment
IDA
RGD
PMID:20837666
RGD:5129167
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
G
Agtr1a
angiotensin II receptor, type 1a
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:8389152 PMID:18421211
RGD:2292665
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
G
Agtr2
angiotensin II receptor, type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8389152
NCBI chr X:112,119,876...112,124,060
Ensembl chr X:112,120,228...112,124,057
G
Akt1
AKT serine/threonine kinase 1
ISO
RGD
PMID:17210696
RGD:2315600
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Akt2
AKT serine/threonine kinase 2
ISO
RGD
PMID:17210696
RGD:2315600
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
G
Alcam
activated leukocyte cell adhesion molecule
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:16316942 PMID:16316942
RGD:2306898
NCBI chr11:48,336,123...48,536,296
Ensembl chr11:48,336,169...48,537,954
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
IEP
mRNA:increased expression:mammary gland tumor (rat)
RGD
PMID:18959458
RGD:2313895
NCBI chr12:5,748,941...5,772,986
Ensembl chr12:5,748,944...5,772,986
G
Antxr1
ANTXR cell adhesion molecule 1
disease_progression
ISO
RGD
PMID:22085271
RGD:9684855
NCBI chr 4:119,590,770...119,778,232
Ensembl chr 4:119,590,771...119,778,232
G
Anxa1
annexin A1
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12376462 PMID:16316942 PMID:16316942
RGD:2306898
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
Anxa4
annexin A4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161
G
Apaf1
apoptotic peptidase activating factor 1
IDA
RGD
PMID:14973070
RGD:2325748
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
G
Apoe
apolipoprotein E
ISO
RGD
PMID:22469977
RGD:7771597
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
G
Aqp1
aquaporin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
G
Ar
androgen receptor
IEP
RGD
PMID:12150826
RGD:6482679
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Areg
amphiregulin
ISO IEP
protein:increased expression:mammary gland mRNA:increased expression:mammary gland
RGD
PMID:10225449 PMID:18421211
RGD:2292663 , RGD:2292665
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
G
Arhgap5
Rho GTPase activating protein 5
disease_progression
IEP ISO
mRNA:increased expression:mammary gland
RGD
PMID:10939588 PMID:19703301
RGD:2316183 , RGD:126848766
NCBI chr 6:69,975,904...70,039,299
Ensembl chr 6:69,976,214...70,037,660
G
Atp5if1
ATP synthase inhibitory factor subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 5:144,738,950...144,742,668
Ensembl chr 5:144,738,950...144,742,668
G
Aurka
aurora kinase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12124350
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
G
Bad
BCL2-associated agonist of cell death
treatment severity
IDA IEP
RGD
PMID:23404339 PMID:20732338
RGD:10053670 , RGD:10053708
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
G
Bak1
BCL2-antagonist/killer 1
ISO
RGD
PMID:19222350
RGD:2315700
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
G
Bard1
BRCA1 associated RING domain 1
ISO
RGD
PMID:18443292
RGD:2293149
NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265
G
Basp1
brain abundant, membrane attached signal protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 2:75,816,130...75,863,801
Ensembl chr 2:75,816,122...75,864,043
G
Bax
BCL2 associated X, apoptosis regulator
treatment severity
IDA IEP
RGD
PMID:23404339 PMID:20732338
RGD:10053670 , RGD:10053708
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
treatment
IDA
RGD
PMID:23404339 PMID:22668016
RGD:10053670 , RGD:10054128
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
treatment
IDA
RGD
PMID:23404339
RGD:10053670
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Bgn
biglycan
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35234341
NCBI chr X:151,197,296...151,209,458
Ensembl chr X:151,197,273...151,209,461
G
Brca1
BRCA1, DNA repair associated
susceptibility
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12203372 PMID:22767648 PMID:18443292 PMID:17505536 PMID:12203372
RGD:2293149 , RGD:2293155 , RGD:1599502
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
G
Bst2
bone marrow stromal cell antigen 2
disease_progression
ISO
RGD
PMID:23806386 PMID:23806386
RGD:14398495 , RGD:14398495
NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979
G
Cad
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
disease_progression
IEP
protein:increased expression:mammary gland
RGD
PMID:6030068
RGD:2303540
NCBI chr 6:25,292,133...25,315,078
Ensembl chr 6:25,292,133...25,319,861
G
Capzb
capping actin protein of muscle Z-line subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 5:151,435,600...151,535,409
Ensembl chr 5:151,434,871...151,535,409
G
Car9
carbonic anhydrase 9
IEP
RGD
PMID:17280655
RGD:2293194
NCBI chr 5:57,763,234...57,769,838
Ensembl chr 5:57,763,206...57,769,838
G
Cask
calcium/calmodulin dependent serine protein kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr X:8,899,500...9,243,014
Ensembl chr X:8,899,833...9,238,694
G
Casp1
caspase 1
treatment
ISO
RGD
PMID:10557324
RGD:2315886
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Casp3
caspase 3
treatment severity
IDA IEP
RGD
PMID:23404339 PMID:20732338 PMID:26699876
RGD:10053670 , RGD:10053708 , RGD:13782283
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
treatment
IDA ISO
RGD
PMID:23404339 PMID:23979166 PMID:26699876
RGD:10053670 , RGD:13209143 , RGD:13782283
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
severity
IEP
RGD
PMID:20732338
RGD:10053708
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
severity treatment
IDA ISO IEP
RGD
PMID:17297389 PMID:20012353 PMID:20732338 PMID:26699876
RGD:2315933 , RGD:2315928 , RGD:10053708 , RGD:13782283
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cav1
caveolin 1
onset treatment
ISO
protein:decreased expression:mammary gland
RGD
PMID:9685399 PMID:15355971 PMID:15334058
RGD:2289100 , RGD:2289106 , RGD:8661780
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
G
Ccna2
cyclin A2
ISO
protein:increased expression:mammary gland
RGD
PMID:10713672
RGD:2293347
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
ISO
RGD
PMID:11146550
RGD:2315939
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccnd1
cyclin D1
ISO IEP
protein:decreased expression:mammary gland mRNA:increased expression:mammary gland (rat) mRNA, protein:increased expression:mammary gland (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12376462 PMID:14522882 PMID:16316942 PMID:17440082 PMID:12649181 PMID:12602925 PMID:16316942 PMID:12376462 More...
RGD:2296037 , RGD:2289336 , RGD:2289337 , RGD:2306898 , RGD:2292404
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Ccnd3
cyclin D3
IEP ISO
mRNA, protein:increased expression:mammary gland
RGD
PMID:16311245 PMID:12853979
RGD:2316020 , RGD:2316015
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
G
Ccne1
cyclin E1
IEP
protein:decreased expression:mammary gland
RGD
PMID:12649181 PMID:12602925
RGD:2289336 , RGD:2289337
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
G
Ccnh
cyclin H
IEP ISO
mRNA:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12606953 PMID:12606953
RGD:9590264
NCBI chr 2:15,835,064...15,855,648
Ensembl chr 2:15,834,833...15,855,819
G
Ccr3
C-C motif chemokine receptor 3
ISO
RGD
PMID:21621198
RGD:6893427
NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:123,616,236...123,634,990
G
Ccr5
C-C motif chemokine receptor 5
ISO
RGD
PMID:14597737 PMID:22637726
RGD:8551810 , RGD:8551813
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Cd274
CD274 molecule
treatment
IDA
RGD
PMID:29043842
RGD:40886270
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
Cd40
CD40 molecule
ISO
RGD
PMID:21137078
RGD:8547744
NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
G
Cd44
CD44 molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cdc25a
cell division cycle 25A
ISO
RGD
PMID:17283130 PMID:16951165 PMID:17638870
RGD:2764000 , RGD:2771824 , RGD:2754551
NCBI chr 8:109,864,356...109,882,734
Ensembl chr 8:109,864,478...109,882,701
G
Cdc42
cell division cycle 42
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111
G
Cdh1
cadherin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdh13
cadherin 13
severity
ISO
RGD
PMID:18316604 PMID:18316604
RGD:2293540 , RGD:2293540
NCBI chr19:46,349,562...47,387,462
Ensembl chr19:46,349,430...47,387,459
G
Cdk2
cyclin dependent kinase 2
ISO
RGD
PMID:16924466
RGD:2293558
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Cdk4
cyclin-dependent kinase 4
susceptibility
IEP ISO
protein:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12376462 PMID:14522882 PMID:25221644 PMID:14522882 PMID:16413469
RGD:2293581 , RGD:2293577
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
G
Cdk6
cyclin-dependent kinase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25221644
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
G
Cdkl2
cyclin dependent kinase like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25333262
NCBI chr14:16,027,381...16,063,257
Ensembl chr14:16,028,363...16,063,252
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
treatment
IEP IDA
protein:increased expression:mammary gland
RGD
PMID:15844214 PMID:22651929
RGD:2293626 , RGD:10045559
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
disease_progression
ISO IEP
RGD
PMID:18060046 PMID:20681787
RGD:2289674 , RGD:8552689
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
G
Cdkn2a_v1
cyclin-dependent kinase inhibitor 2A, variant 1
disease_progression
ISO
RGD
PMID:18060046
RGD:2289674
G
Cdkn2a_v2
cyclin-dependent kinase inhibitor 2A, variant 2
disease_progression
ISO
RGD
PMID:18060046
RGD:2289674
G
Cds1
CDP-diacylglycerol synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr14:7,820,328...7,882,943
Ensembl chr14:7,820,351...7,882,681
G
Clu
clusterin
disease_progression
ISO
RGD
PMID:23099883
RGD:8699504
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Cnn3
calponin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 2:209,518,948...209,550,107
Ensembl chr 2:209,518,948...209,550,104
G
Col18a1
collagen type XVIII alpha 1 chain
severity
IDA
RGD
PMID:10766159
RGD:70690
NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593
G
Col5a1
collagen type V alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588
G
Csf1
colony stimulating factor 1
ISO
RGD
PMID:15205327
RGD:2293710
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
G
Csn2
casein beta
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:9879772 PMID:16316942 PMID:16316942
RGD:2306898
NCBI chr14:20,322,581...20,329,818
Ensembl chr14:20,322,581...20,329,817
G
Csn3
casein kappa
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:16316942 PMID:16316942
RGD:2306898
NCBI chr14:20,154,032...20,160,585
Ensembl chr14:20,154,032...20,160,587
G
Csnk2a1
casein kinase 2 alpha 1
IEP ISO
RGD
PMID:11827167 PMID:11827167
RGD:727632 , RGD:727632
NCBI chr 3:140,709,984...140,756,757
Ensembl chr 3:140,709,991...140,756,696
G
Ctnnb1
catenin beta 1
ISO
DNA:missense mutations: :p.S33Y, p.S45F protein:increased expression:mammary gland
RGD
PMID:18060046 PMID:17510243
RGD:2289674 , RGD:2289816
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
G
Dbi
diazepam binding inhibitor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693
G
Ddr1
discoidin domain receptor tyrosine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21283680 PMID:29298894
RGD:151347446
NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
G
Des
desmin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 9:76,850,979...76,858,695
Ensembl chr 9:76,850,982...76,858,699
G
Dio1
iodothyronine deiodinase 1
IDA
RGD
PMID:11765219
RGD:727335
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
G
Dnmt3b
DNA methyltransferase 3 beta
treatment
IEP
RGD
PMID:24447120
RGD:9588304
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
G
Dusp1
dual specificity phosphatase 1
treatment
ISO
RGD
PMID:20837666
RGD:5129167
NCBI chr10:16,680,478...16,683,275
G
Dusp6
dual specificity phosphatase 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
Eef1a1
eukaryotic translation elongation factor 1 alpha 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 8:79,341,554...79,344,784
Ensembl chr 8:79,341,557...79,344,839
G
Efemp1
EGF containing fibulin extracellular matrix protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr14:102,610,813...102,690,027
Ensembl chr14:102,610,908...102,690,018
G
Egfr
epidermal growth factor receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:2523869 PMID:8603490 PMID:17203220
RGD:2289979
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Eif5a
eukaryotic translation initiation factor 5A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:54,640,104...54,644,845
Ensembl chr10:54,640,024...54,644,656
G
Eno1
enolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336 Ensembl chr 3:160,719,951...160,731,336
G
Epcam
epithelial cell adhesion molecule
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
G
Ephx1
epoxide hydrolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
G
Epo
erythropoietin
treatment
IMP
RGD
PMID:12118093
RGD:11041669
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
G
Epor
erythropoietin receptor
treatment
IMP
RGD
PMID:12118093
RGD:11041669
NCBI chr 8:20,489,678...20,494,257
Ensembl chr 8:20,489,678...20,494,257
G
Erbb2
erb-b2 receptor tyrosine kinase 2
IDA ISO
CTD Direct Evidence: marker/mechanism Androgen-dependent
CTD RGD
PMID:8603490 PMID:25221644 PMID:1913683 PMID:17203220 PMID:12150826
RGD:2289920 , RGD:2289979 , RGD:6482679
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
G
Erbb3
erb-b2 receptor tyrosine kinase 3
ISO
RGD
PMID:17203220
RGD:2289979
NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
G
Erbb4
erb-b2 receptor tyrosine kinase 4
ISO
RGD
PMID:17203220
RGD:2289979
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
G
Esr1
estrogen receptor 1
susceptibility
ISO IEP
protein:increased expression:epithelial cell, nucleus CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15637090 PMID:18055862 PMID:15637090 PMID:11759285
RGD:2290019 , RGD:8552983 , RGD:8553057
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Esr2
estrogen receptor 2
treatment
IDA IEP ISO
protein:increased expression:epithelial cell, nucleus CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15637090 PMID:24078029 PMID:15637090
RGD:7364911 , RGD:8552983
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Ezr
ezrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
G
F11r
F11 receptor
ISO
RGD
PMID:22120722
RGD:7488922
NCBI chr13:83,873,797...83,897,388
Ensembl chr13:83,873,797...83,897,402
G
Fabp4
fatty acid binding protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
G
Fas
Fas cell surface death receptor
ISO
RGD
PMID:18094967
RGD:2290047
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
G
Fbxo10
F-box protein 10
IEP
RGD
PMID:17404222
RGD:1601189
NCBI chr 5:59,297,016...59,343,429
Ensembl chr 5:59,297,045...59,343,348
G
Fgf10
fibroblast growth factor 10
IEP
mRNA:increased expression:mammary gland
RGD
PMID:18421211
RGD:2292665
NCBI chr 2:50,801,171...50,878,218
Ensembl chr 2:50,800,992...50,876,866
G
Fgf7
fibroblast growth factor 7
ISO
RGD
PMID:9000125
RGD:2301094
NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929
G
Fgf8
fibroblast growth factor 8
ISO
RGD
PMID:9840935
RGD:2301098
NCBI chr 1:244,584,477...244,590,578
Ensembl chr 1:244,584,652...244,590,359
G
Flt3
Fms related receptor tyrosine kinase 3
ISO
RGD
PMID:10498246
RGD:2302211
NCBI chr12:7,623,930...7,699,474
Ensembl chr12:7,623,930...7,699,474
G
Fn1
fibronectin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Frmpd1
FERM and PDZ domain containing 1
IEP
RGD
PMID:17404222
RGD:1601189
NCBI chr 5:59,443,076...59,545,125
Ensembl chr 5:59,443,076...59,545,080
G
Furin
furin (paired basic amino acid cleaving enzyme)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 1:134,348,142...134,361,182
Ensembl chr 1:134,348,144...134,364,314
G
G0s2
G0/G1switch 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr13:104,806,351...104,807,263
Ensembl chr13:104,806,156...104,807,451
G
Gata3
GATA binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr17:68,643,760...68,666,000
Ensembl chr17:68,643,873...68,665,391
G
Gatm
glycine amidinotransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 3:109,658,919...109,675,508
Ensembl chr 3:109,658,951...109,684,129
G
Gda
guanine deaminase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:218,903,045...218,982,360
Ensembl chr 1:218,906,815...218,982,416
G
Ggt1
gamma-glutamyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
G
Gh1
growth hormone 1
treatment
IMP IDA ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12082019 PMID:15528971 PMID:17584969 PMID:17584969 PMID:6139974
RGD:2315650 , RGD:11352806
NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
G
Gnai2
G protein subunit alpha i2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
G
Gsk3b
glycogen synthase kinase 3 beta
treatment
IDA
RGD
PMID:28810530
RGD:13792729
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
G
Gsn
gelsolin
IEP
mRNA:decreased expression
RGD
PMID:8895730
RGD:1599869
NCBI chr 3:18,585,166...18,638,404
Ensembl chr 3:18,585,172...18,638,402
G
Gss
glutathione synthetase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 3:144,047,849...144,078,197
Ensembl chr 3:144,047,850...144,078,198
G
H19
H19 imprinted maternally expressed transcript
IEP
RGD
PMID:15170812
RGD:1642758
NCBI chr 1:197,730,698...197,733,374
Ensembl chr 1:197,730,698...197,733,134
G
H2ax
H2A.X variant histone
treatment
ISO
RGD
PMID:22384017
RGD:7240549
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
G
H3f3b
H3.3 histone B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:101,256,484...101,258,716
Ensembl chr10:101,256,480...101,258,709 Ensembl chr13:101,256,480...101,258,709
G
Hba-a2
hemoglobin alpha, adult chain 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr10:15,323,830...15,324,677
Ensembl chr10:15,307,815...15,338,392 Ensembl chr10:15,307,815...15,338,392
G
Hif1a
hypoxia inducible factor 1 subunit alpha
treatment
IDA
RGD
PMID:17280655
RGD:2293194
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Hmox1
heme oxygenase 1
treatment
IDA ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:16319139 PMID:23215791
RGD:10755708
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
G
Hnrnpab
heterogeneous nuclear ribonucleoprotein A/B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15538050
NCBI chr10:35,857,040...35,862,935
Ensembl chr10:35,857,041...35,863,344
G
Hp
haptoglobin
treatment
IDA
RGD
PMID:23880232
RGD:11041861
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
G
Hras
HRas proto-oncogene, GTPase
IAGP ISO
DNA:mutation: :p.G12E (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:8185828 PMID:11376698 PMID:19652463
RGD:2314834
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
G
Id1
inhibitor of DNA binding 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
G
Id3
inhibitor of DNA binding 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
G
Id4
inhibitor of DNA binding 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14633621
NCBI chr17:16,389,387...16,391,956
Ensembl chr17:16,389,387...16,392,470
G
Igf1
insulin-like growth factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15217511 PMID:15528971 PMID:17584969 PMID:23342276
RGD:8549490
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Il10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14999141
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il18bp
interleukin 18 binding protein
IEP
mRNA:increased expression:mammary gland
RGD
PMID:18959458
RGD:2313895
NCBI chr 1:156,372,923...156,374,963
Ensembl chr 1:156,372,883...156,374,963
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
human protein in a mouse model
RGD
PMID:21890879
RGD:6771361
NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
G
Il6st
interleukin 6 cytokine family signal transducer
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
G
Ilk
integrin-linked kinase
ISO
late onset development of tumors in transgenic mice overexpressing human ILK in mammary glands
RGD
PMID:11704830
RGD:2301733
NCBI chr 1:160,088,839...160,095,140
Ensembl chr 1:160,088,897...160,095,140
G
Insig1
insulin induced gene 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
G
Itgb3
integrin subunit beta 3
IEP
protein:increased expression:mammary gland:
RGD
PMID:22022542
RGD:8693386
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
G
Kdr
kinase insert domain receptor
IDA ISO
inhibition prevents DMBA-induced atypical ductal hyperplasia and carcinoma in situ
RGD
PMID:15170218 PMID:19888452
RGD:2291936 , RGD:5684399
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
G
Kit
KIT proto-oncogene receptor tyrosine kinase
IAGP
DNA:mutation (rat)
RGD
PMID:18445266
RGD:2302172
NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652
G
Kitlg
KIT ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
G
Krt5
keratin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 7:132,846,132...132,851,861
Ensembl chr 7:132,846,136...132,851,850
G
Krt7
keratin 7
IEP
RGD
PMID:8570173
RGD:2317439
NCBI chr 7:132,528,881...132,545,052
Ensembl chr 7:132,528,895...132,545,052
G
Krt71
keratin 71
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:132,873,532...132,898,975
Ensembl chr 7:132,873,540...132,882,325
G
Lep
leptin
treatment
IEP
RGD
PMID:22246620
RGD:8694468
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lgals7
galectin 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:84,148,612...84,152,016
Ensembl chr 1:84,150,252...84,152,015
G
Lhcgr
luteinizing hormone/choriogonadotropin receptor
IMP
mRNA:splice variant (rat)
RGD
PMID:15044717
RGD:2302177
NCBI chr 6:5,661,871...5,728,109
Ensembl chr 6:5,661,871...5,724,521
G
Lin7a
lin-7 homolog A, crumbs cell polarity complex component
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 7:42,586,704...42,742,609
Ensembl chr 7:42,586,719...42,730,550
G
Lnpep
leucyl and cystinyl aminopeptidase
IEP ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16619500 PMID:16619500
RGD:1582109
NCBI chr 1:58,258,642...58,355,532
Ensembl chr 1:58,258,642...58,354,544
G
Lpl
lipoprotein lipase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Lsr
lipolysis stimulated lipoprotein receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 1:86,185,769...86,201,952
Ensembl chr 1:86,186,431...86,201,952
G
Map2k3
mitogen activated protein kinase kinase 3
ISO
RGD
PMID:24233520
RGD:7495808
NCBI chr10:45,608,145...45,629,492
Ensembl chr10:45,607,163...45,629,492
G
Map2k7
mitogen activated protein kinase kinase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21317887
NCBI chr12:2,591,312...2,600,534
Ensembl chr12:2,591,219...2,604,222
G
Mapk1
mitogen activated protein kinase 1
treatment
IDA
RGD
PMID:29435821
RGD:13800872
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
treatment
IDA
RGD
PMID:29435821
RGD:13800872
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mdh2
malate dehydrogenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr12:20,894,269...20,907,225
Ensembl chr12:20,894,262...20,907,271
G
Mgp
matrix Gla protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 4:169,766,290...169,769,612
Ensembl chr 4:169,766,279...169,769,667
G
Mif
macrophage migration inhibitory factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504 Ensembl chr 4:12,790,902...12,799,504
G
Mir155
microRNA 155
ISO
RGD
PMID:20354188 PMID:29643534
RGD:21079418 , RGD:21403681
NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
G
Mmp1
matrix metallopeptidase 1
treatment
ISO
RGD
PMID:19622769
RGD:8549722
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Mmp13
matrix metallopeptidase 13
severity
ISO
RGD
PMID:18698413
RGD:2306081
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
G
Mmp15
matrix metallopeptidase 15
ISO
mRNA:increased expression:mammary gland
RGD
PMID:15895410
RGD:2314949
NCBI chr19:9,663,449...9,684,943
Ensembl chr19:9,663,449...9,684,943
G
Mmp2
matrix metallopeptidase 2
treatment
IEP ISO
protein:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:28574600 PMID:19725228 PMID:23359979
RGD:2325823 , RGD:8657038
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
G
Mmp3
matrix metallopeptidase 3
IMP
RGD
PMID:10428026
RGD:8662909
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Mmp7
matrix metallopeptidase 7
onset
ISO
RGD
PMID:9850086
RGD:9685350
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
G
Mmp9
matrix metallopeptidase 9
treatment
IEP ISO
mRNA, protein:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21283680 PMID:19725228 PMID:23359979
RGD:2325823 , RGD:8657038
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mpzl1
myelin protein zero-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr13:77,852,467...77,889,305
Ensembl chr13:77,852,467...77,896,616
G
Mrc2
mannose receptor, C type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:90,261,986...90,323,187
Ensembl chr10:90,261,394...90,322,856
G
Mt-co1
mitochondrially encoded cytochrome c oxidase I
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
G
Mtor
mechanistic target of rapamycin kinase
IMP
RGD
PMID:22349822
RGD:10040957
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Muc1
mucin 1, cell surface associated
treatment
ISO
RGD
PMID:23015160
RGD:7349374
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
G
Myc
MYC proto-oncogene, bHLH transcription factor
treatment
ISO
RGD
PMID:22384017
RGD:7240549
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Ncoa1
nuclear receptor coactivator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21080969
NCBI chr 6:27,232,609...27,507,992
Ensembl chr 6:27,232,611...27,475,664
G
Nfe2l2
NFE2 like bZIP transcription factor 2
treatment
IEP
RGD
PMID:22072621
RGD:10412719
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Notch4
notch receptor 4
ISO
RGD
PMID:15531924
RGD:2299154
NCBI chr20:4,160,362...4,184,466
Ensembl chr20:4,160,445...4,184,465
G
Nsmf
NMDA receptor synaptonuclear signaling and neuronal migration factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 3:7,861,846...7,870,615
Ensembl chr 3:7,861,872...7,870,614
G
Nudt1
nudix hydrolase 1
IEP
mRNA:increased expression:mammary gland
RGD
PMID:12036445
RGD:724605
NCBI chr12:14,302,514...14,309,559
Ensembl chr12:14,302,694...14,305,826
G
Oxt
oxytocin/neurophysin I prepropeptide
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:8647655 PMID:15089975
NCBI chr 3:117,782,650...117,783,490
Ensembl chr 3:117,782,650...117,783,490
G
Padi4
peptidyl arginine deiminase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 5:153,041,351...153,074,412
Ensembl chr 5:153,041,352...153,074,362
G
Pak4
p21 (RAC1) activated kinase 4
ISO
RGD
PMID:20697354
RGD:7775027
NCBI chr 1:83,849,904...83,889,188
Ensembl chr 1:83,849,904...83,859,413
G
Parp1
poly (ADP-ribose) polymerase 1
treatment
IDA
RGD
PMID:23404339
RGD:10053670
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pcna
proliferating cell nuclear antigen
IEP
mRNA,protein:increased expression:mammary gland:
RGD
PMID:2567593
RGD:10448972
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pcp4
Purkinje cell protein 4
IEP
mRNA,protein:increased expression:cytoplasm:
RGD
PMID:19480007
RGD:9850273
NCBI chr11:35,759,711...35,861,725
Ensembl chr11:35,800,713...35,861,725
G
Pdgfa
platelet derived growth factor subunit A
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland (rat) mRNA, protein:increased expression:mammary gland (rat)
CTD RGD
PMID:12376462 PMID:16316942 PMID:16316942 PMID:12376462
RGD:2306898 , RGD:2292404
NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
G
Pebp1
phosphatidylethanolamine binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr12:39,302,864...39,307,064
Ensembl chr12:39,302,840...39,307,862
G
Pgam1
phosphoglycerate mutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:240,723,832...240,731,443
Ensembl chr 1:240,723,920...240,738,452
G
Pgr
progesterone receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15637090
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
G
Phb1
prohibitin 1
IEP ISO
mRNA, protein:increased expression:mammary gland CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12376462 PMID:12376462
RGD:2292404
NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:32,882,032...32,963,631
G
Pin1
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
IEP
RGD
PMID:22064478
RGD:8693420
NCBI chr 8:19,189,408...19,200,785
Ensembl chr 8:19,189,373...19,200,785
G
Pkm
pyruvate kinase M1/2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
G
Plau
plasminogen activator, urokinase
disease_progression
IMP
RGD
PMID:18052026
RGD:6484140
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
G
Plk2
polo-like kinase 2
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:mammary gland (rat)
CTD RGD
PMID:12376462 PMID:12376462
RGD:2292404
NCBI chr 2:41,969,176...41,974,945
Ensembl chr 2:41,969,176...41,974,947
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11137312
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Prdx2
peroxiredoxin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
G
Prl
prolactin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Prlr
prolactin receptor
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:16316942 PMID:16316942
RGD:2306898
NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:59,134,588...59,324,718
G
Psma4
proteasome 20S subunit alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 8:55,340,431...55,347,893
Ensembl chr 8:55,340,386...55,347,890
G
Psme1
proteasome activator subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr15:29,069,012...29,071,888
Ensembl chr15:29,068,729...29,071,890
G
Ptbp1
polypyrimidine tract binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 7:9,842,574...9,852,332
Ensembl chr 7:9,842,574...9,852,397
G
Pten
phosphatase and tensin homolog
onset
ISO
RGD
PMID:18381417
RGD:2292496
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
G
Ptger1
prostaglandin E receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11751431
NCBI chr19:24,470,258...24,473,687
Ensembl chr19:24,467,532...24,473,559
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IEP IMP ISO
mRNA:increased expression:breast
RGD
PMID:21623034 PMID:18279516 PMID:18676768
RGD:5135030 , RGD:2300130 , RGD:2300118
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptk2
protein tyrosine kinase 2
disease_progression
ISO IMP
CTD Direct Evidence: therapeutic
CTD RGD
PMID:24809783 PMID:18056629 PMID:15930288
RGD:2292554 , RGD:2292560
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
G
Ptn
pleiotrophin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 4:65,293,731...65,375,572
Ensembl chr 4:65,293,734...65,375,456
G
Ptprb
protein tyrosine phosphatase, receptor type, B
treatment
ISO
RGD
PMID:23899555
RGD:151660352
NCBI chr 7:51,953,375...52,034,751
Ensembl chr 7:51,930,015...52,034,748
G
Ran
RAN, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr12:27,674,049...27,678,598
Ensembl chr12:27,674,050...27,678,276
G
Rasa1
RAS p21 protein activator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr 2:15,857,704...15,940,757
Ensembl chr 2:15,857,980...15,940,854
G
Rasgrf2
RAS protein-specific guanine nucleotide-releasing factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12606953
NCBI chr 2:23,113,613...23,361,537
Ensembl chr 2:23,117,004...23,361,240
G
Rb1
RB transcriptional corepressor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14522882
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Rbp1
retinol binding protein 1
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:mammary gland (rat)
CTD RGD
PMID:12376462 PMID:12376462
RGD:2292404
NCBI chr 8:99,025,218...99,046,740
Ensembl chr 8:99,025,206...99,046,743
G
Rbp4
retinol binding protein 4
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:16316942 PMID:16316942
RGD:2306898
NCBI chr 1:235,893,917...235,901,315
Ensembl chr 1:235,893,917...235,901,399
G
Rcn1
reticulocalbin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 3:91,841,052...91,855,295
Ensembl chr 3:91,841,052...91,855,295
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
protein:decreased expression:peritoneal macrophage
RGD
PMID:16288051
RGD:2298764
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Relb
RELB proto-oncogene, NF-kB subunit
ISO
RGD
PMID:16260626
RGD:7777148
NCBI chr 1:79,257,738...79,285,490
Ensembl chr 1:79,257,725...79,285,507
G
Rnpep
arginyl aminopeptidase
IEP ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16619500 PMID:16619500
RGD:1582109
NCBI chr13:46,699,458...46,717,829
Ensembl chr13:46,699,463...46,717,998
G
Rpl3
ribosomal protein L3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:111,622,255...111,627,640
Ensembl chr 7:111,621,610...111,636,468
G
Rpl6
ribosomal protein L6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr12:35,347,493...35,352,011
Ensembl chr12:35,347,497...35,351,921
G
Rps14
ribosomal protein S14
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr18:54,227,854...54,232,638
Ensembl chr18:54,227,854...54,233,166
G
Runx1
RUNX family transcription factor 1
IEP
mRNA:increased expression:mammary gland
RGD
PMID:29435983
RGD:126779584
NCBI chr11:31,839,880...32,074,427
Ensembl chr11:31,843,764...32,074,542
G
Rxra
retinoid X receptor alpha
IMP
RGD
PMID:16344269
RGD:1643109
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
G
S100a6
S100 calcium binding protein A6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 2:176,100,619...176,102,181
Ensembl chr 2:176,100,899...176,102,180
G
S1pr1
sphingosine-1-phosphate receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 2:203,624,752...203,629,110
Ensembl chr 2:203,621,587...203,629,681
G
Scarb1
scavenger receptor class B, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
G
Scd
stearoyl-CoA desaturase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Selenop
selenoprotein P
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852
G
Sgk1
serum/glucocorticoid regulated kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
G
Slc12a2
solute carrier family 12 member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr18:51,348,282...51,416,448
Ensembl chr18:51,348,302...51,416,440
G
Slc25a10
solute carrier family 25 member 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr10:105,765,598...105,775,159
Ensembl chr10:105,765,372...105,773,556
G
Sncg
synuclein, gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr16:9,700,513...9,705,751
Ensembl chr16:9,700,514...9,705,368
G
Snrpd3
small nuclear ribonucleoprotein D3 polypeptide
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr20:13,130,112...13,145,947
Ensembl chr20:13,130,119...13,145,978
G
Socs1
suppressor of cytokine signaling 1
ISO
mRNA:increased expression:mammary gland
RGD
PMID:18381452 PMID:20354188
RGD:2298899 , RGD:21079418
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
G
Socs3
suppressor of cytokine signaling 3
ISO
mRNA:increased expression:mammary gland
RGD
PMID:18381452
RGD:2298899
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
G
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23964924
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sox9
SRY-box transcription factor 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
G
Spint2
serine peptidase inhibitor, Kunitz type, 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:84,558,159...84,580,616
Ensembl chr 1:84,558,166...84,580,616
G
Spp1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15318939
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Srsf2
serine and arginine rich splicing factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr10:102,052,158...102,055,365
Ensembl chr10:102,052,314...102,055,338
G
Stat1
signal transducer and activator of transcription 1
ISO
RGD
PMID:11325527
RGD:2291895
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Stat3
signal transducer and activator of transcription 3
ISO IEP
CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland (rat)
CTD RGD
PMID:16316942 PMID:17483332 PMID:16316942
RGD:2291914 , RGD:2306898
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stat5a
signal transducer and activator of transcription 5A
susceptibility
IEP ISO
protein:increased tyrosine phosphorylation:mammary gland protein:altered localization:nucleus CTD Direct Evidence: marker/mechanism mRNA:increased expression:mammary gland (rat) mRNA, protein:increased expression:mammary gland (rat)
CTD RGD
PMID:12376462 PMID:15609129 PMID:16316942 PMID:17173897 PMID:12082622 PMID:15609129 PMID:16316942 PMID:12376462 PMID:20181624 More...
RGD:2291927 , RGD:2298539 , RGD:2291932 , RGD:2306898 , RGD:2292404 , RGD:151665819
NCBI chr10:85,785,537...85,809,869
Ensembl chr10:85,785,537...85,809,866
G
Stat6
signal transducer and activator of transcription 6
ISO
RGD
PMID:11086031
RGD:2298563
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
G
Stc2
stanniocalcin 2
IEP
mRNA:increased expression:mammary gland
RGD
PMID:18959458
RGD:2313895
NCBI chr10:16,251,046...16,260,815
Ensembl chr10:16,250,853...16,262,973
G
Stmn1
stathmin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
G
Tdg
thymine-DNA glycosylase
ISO
mRNA:increased expression:mammary gland tumor (mouse)
RGD
PMID:9794235
RGD:2317355
NCBI chr 7:21,077,853...21,097,617
Ensembl chr 7:21,077,853...21,097,567
G
Terc
telomerase RNA component
ISO
RNA:increased expression:mammary gland
RGD
PMID:9857231
RGD:2291975
NCBI chr 2:112,815,654...112,816,041
G
Tf
transferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9879772 PMID:16316942
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
G
Tff1
trefoil factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
G
Tgfa
transforming growth factor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8603490
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
G
Tgfb1
transforming growth factor, beta 1
ISO
RGD
PMID:8466857
RGD:7394797
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tgfbr1
transforming growth factor, beta receptor 1
ISO
RGD
PMID:12808151
RGD:737735
NCBI chr 5:61,653,773...61,710,777
Ensembl chr 5:61,653,233...61,710,777
G
Tgfbr2
transforming growth factor, beta receptor 2
ISO
RGD
PMID:12808151
RGD:737735
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
G
Thbs1
thrombospondin 1
IEP
mRNA:increased expression:mammary gland
RGD
PMID:15459484
RGD:1626167
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Thrsp
thyroid hormone responsive
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075
G
Tkt
transketolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr16:5,723,764...5,748,702
Ensembl chr16:5,723,762...5,748,698
G
Tle4
TLE family member 4, transcriptional corepressor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 1:211,661,738...211,798,458
Ensembl chr 1:211,661,746...211,797,862
G
Tnf
tumor necrosis factor
ISO
RGD
PMID:19755514
RGD:7401185
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfrsf10b
TNF receptor superfamily member 10b
ISO
RGD
PMID:17671220
RGD:2290495
NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467
G
Tnfsf10
TNF superfamily member 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21252285
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Tp53
tumor protein p53
disease_progression
IEP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:24809783 PMID:17470299 PMID:18092324
RGD:2290577 , RGD:2290539
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Tpm3
tropomyosin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462 PMID:16316942
NCBI chr 2:175,517,198...175,545,014
Ensembl chr 2:175,517,226...175,545,013
G
Trps1
transcriptional repressor GATA binding 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 7:81,916,668...82,142,733
Ensembl chr 7:81,921,601...82,141,905
G
Tsc22d1
TSC22 domain family, member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr15:51,750,489...51,850,958
Ensembl chr15:51,749,510...51,850,958
G
Tubb2b
tubulin, beta 2B class IIb
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr17:30,747,734...30,750,781
Ensembl chr17:30,747,734...30,750,638
G
Txnip
thioredoxin interacting protein
severity
IEP
mRNA:decreased expression:mammary gland
RGD
PMID:15170812
RGD:1642758
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
G
Tyms
thymidylate synthetase
IMP
RGD
PMID:9635926
RGD:2315839
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
G
Ube2i
ubiquitin-conjugating enzyme E2I
ISO
MCF-7 human breast cancer cell tumors grown in nude mice CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16316942 PMID:15735760
RGD:2301345
NCBI chr10:14,277,749...14,294,681
Ensembl chr10:69,701,618...69,702,443 Ensembl chr10:69,701,618...69,702,443
G
Ucp2
uncoupling protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
G
Vamp8
vesicle-associated membrane protein 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16316942
NCBI chr 4:104,442,383...104,452,884
Ensembl chr 4:104,442,393...104,452,897
G
Vdr
vitamin D receptor
ISO
RGD
PMID:15333467
RGD:8158073
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Vegfa
vascular endothelial growth factor A
treatment
ISO
human protein in a mouse model
RGD
PMID:21890879
RGD:6771361
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Wnt1
Wnt family member 1
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298863 , RGD:2298848
NCBI chr 7:129,938,604...129,942,651
Ensembl chr 7:129,938,604...129,942,651
G
Wnt2
Wnt family member 2
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298863 , RGD:2298848
NCBI chr 4:46,328,408...46,374,673
Ensembl chr 4:46,333,998...46,374,402
G
Wnt3
Wnt family member 3
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:9419423
RGD:2298848
NCBI chr10:88,680,198...88,724,170
Ensembl chr10:88,680,248...88,724,099
G
Wnt3a
Wnt family member 3A
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:9419423 PMID:8065359
RGD:2298848 , RGD:2298863
NCBI chr10:44,034,174...44,078,366
Ensembl chr10:44,034,194...44,078,324
G
Wnt5b
Wnt family member 5B
no_association
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298863 , RGD:2298848
NCBI chr 4:152,609,566...152,733,790
Ensembl chr 4:152,609,569...152,733,407
G
Wnt6
Wnt family member 6
no_association
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298863 , RGD:2298848
NCBI chr 9:76,329,882...76,343,523
Ensembl chr 9:76,329,882...76,343,523
G
Wnt7a
Wnt family member 7A
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298863 , RGD:2298848
NCBI chr 4:123,863,108...123,908,981
Ensembl chr 4:123,863,108...123,908,981
G
Wnt7b
Wnt family member 7B
no_association
ISO
in vitro transformation of transfected C57MG mammary epithelial cell line
RGD
PMID:8065359 PMID:9419423
RGD:2298863 , RGD:2298848
NCBI chr 7:116,634,817...116,679,459
Ensembl chr 7:116,634,814...116,679,581
G
Xdh
xanthine dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
G
Xiap
X-linked inhibitor of apoptosis
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12766084
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
G
Xrcc3
X-ray repair cross complementing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21283680
NCBI chr 6:130,863,405...130,873,765
Ensembl chr 6:130,863,959...130,872,444
G
Ywhaz
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12376462
NCBI chr 7:67,941,353...67,963,651
Ensembl chr 7:67,940,017...67,963,668
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all